QUICKLINKS AND VIEW OPITONS
Phentermine: ‘Low rate of serious adverse effects’
Thursday, March 04, 2010 8:55 am Email this article
"Patients taking oral stimulants, as prescribed by a physician, simply do not achieve the high plasma drug levels needed to produce serious adverse effects. This fact likely explains the overall very low rate of serious adverse effects seen with the use of stimulants for the treatment of attention deficit disorder and obesity," according to a recent letter by Rothman, MD, PhD, Chief of the Psychopharmacology Section at the National Institutes of Health, and Ed Hendricks, MD from Roseville, California published in the American Journal Of Emergency Medicine. REFERENCE
Rothman R, Hendricks E. Phentermine cardiovascular safety. Am J Emerg Med. 2009 Oct, 27(8):1010-13.
AUTHOR’S CONTACT INFORMATION
Richard Rothman, MD, PhD
Chief, Clinical Psychopharmacology Section
Intramural Research Program
National Institutes of Health, National Institute on Drug Abuse
Department of Health and Human Services
JHU Bayview Medical Center Triad Bldg/4508
Baltimore, MD 21224, USA
Richard B. Rothman MD, PhD
BeLite Medical Center
Fairfax, VA 22030
Ed J. Hendricks, MD
The Center for Weight Management
2310 Professional Dr., St. 200
Roseville, California 95661
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.